Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endothelial Microparticles as Biomarker for Rejection in Kidney Transplant
NCT03098238Completed
- Sponsor
- CHU Montpellier
- Start
- Nov 2017
- Primary completion
- Jun 2020
- Countries
- 1
01
Overview
Open-label trial (3 arms), sponsored by CHU Montpellier. Primary endpoint: Plasma concentration of endothelial microparticles at 1 day. Started Nov 2017; status: completed.
Beyond the preview
Go deeper on NCT03098238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03098238.